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Abstract 
 
Hyaluronic acid is a naturally occurring linear polysaccharide identified in all periodontal tissues 
in varying quantities. It is a very promising alternative as a mediator of periodontal tissue 
regeneration, because of its vast presence in periodontal tissues and its anti-inflammatory capacity. 
The objective of this literature review was to evaluate the potential of hyaluronic acid in the 
treatment of periodontal inflammation.  
A survey was conducted between November 2016 and March 2017 in MEDLINE, B-on, Scopus 
and Google Scholar database. Manuscript analysis was substantiated on Meta-Analysis Reporting 
Standards. The languages elected for articles selection were English, French, Portuguese and 
Spanish, and the time limit was the period from 2007 to 2017. That search resulted in 33 articles 
with the eligibility criteria.  
Hyaluronic acid has shown anti-inflammatory, anti-oedematous and anti-bacterial effects in the 
treatment of periodontal diseases. In the treatment of gingivitis or periodontitis, hyaluronic acid 
presents advantages when used alone or used as an adjuvant. 
Despite hyaluronic acid identified properties, further long-term studies need to be carried out 
discussing application time, quantity of application, different forms and concentrations. These 
studies could also optimize administration protocols and establish proper recommendations for its 
use. 
Hyaluronic acid presents beneficial effects on periodontal inflammation, with importance on a 
microbiological level with favorable clinical outcomes. 
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Resumo  
O ácido hialurónico é um polissacarídeo linear naturalmente identificado em todos os tecidos 
periodontais, em quantidades variadas. É uma alternativa muito promissora como mediador da 
regeneração periodontal, devido à sua vasta presença nos tecidos periodontais e à sua capacidade 
anti-inflamatória. 
O objetivo deste trabalho de revisão bibliográfica foi avaliar o potencial do ácido hialurónico no 
tratamento da inflamação periodontal. 
Foi realizada uma pesquisa bibliográfica entre novembro de 2016 e março de 2017 nas bases de 
dados MEDLINE, B-on, Scopus e Google Scholar. A análise de cada artigo fundamentou-se nos 
critérios de meta-análise: Meta-Analysis Reporting Standards. Os idiomas destacados para a 
seleção dos artigos foram: inglês, francês, português e espanhol. O período de revisão foi de 2007 
a 2017. Essa pesquisa resultou em 33 artigos com os critérios de elegibilidade. 
O ácido hialurónico tem demonstrado efeito anti-inflamatório, anti-edematoso e anti-bacteriano no 
tratamento da doença periodontal. No tratamento da gengivite ou periodontite o ácido hialurónico 
apresenta vantagens quando usado isoladamente ou utilizado como adjuvante. 
Apesar das propriedades comprovadas do ácido hialurónico, mais estudos deverão ser realizados 
discutindo o tempo de aplicação, quantidade de aplicação, diferentes formas de apresentação e 
concentrações a utilizar. Estes estudos favorecerão uma melhor compreensão do efeito terapêutico 
do acido hialurónico permitindo optimizar os protocolos de administração e estabelecer 
recomendações adequadas para o seu uso. 
Comprova-se que o ácido hialurónico tem efeitos benéficos sobre a inflamação periodontal, com 
importância a nível microbiológico e por isso com resultados clínicos favoráveis.  
 
Palavras-chaves: Ácido hialurônico, inflamação gengival, doença periodontal, regeneração 
periodontal. 
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I. INTRODUCTION 
The periodontium is a set of specialized tissues that both surround and support the teeth. Those 
tissues show a particular conformation in witch non-mineralized and mineralized tissues coexist in 
a perfect symbiosis, and work like a barrier against microbial invasion which is essential to prevent 
the destruction of periodontal tissues (alveolar bone, cementum, and periodontal ligament). Indeed, 
the crossing of this obstacle by microbial agents can lead to chronical inflammation, such as 
periodontal disease (Gontiya G, Galgali SR, 2012). 
Periodontal diseases are a common inflammatory disorder known as gingivitis and periodontitis. 
They result in the destruction of the tissues surrounding and supporting the teeth, leading to tooth 
loss (Muhammad Ashraf Nazir, 2017). 
 
Hyaluronic acid (HA) is a high molecular weight polysaccharide (glycosaminoglycan), which 
plays a vital role in the functioning of extracellular matrices, including those of mineralized and 
non-mineralized periodontal tissues (Vera RN et al., 2013). 
It has already been used in the treatment of the inflammatory process in various domains such as 
orthopedics, dermatology and ophthalmology. In dentistry, it played a role in the 
temporomandibular joint disorders, and more recently in the treatment of periodontal disease 
thanks to its anti-inflammatory, anti-oedematous and anti-bacterial effects (Parveen D, Reet K, 
2013). 
With the realisation of this work of literature review, we attempted to evaluate the involvement of 
HA in the periodontal regulation of inflammation and periodontal regeneration. So the aim of this 
study was to know if HA presents good results in the treatment of periodontal inflammation. 
A survey was conducted between November 2016 and March 2017 in MEDLINE, B-on, Scopus 
and Google Scholar database, using the following terms in different combinations: hyaluronic 
acid, gingival inflammation, periodontal disease, periodontal regeneration. Manuscript analysis 
was substantiated on Meta-Analysis Reporting Standards. Only articles in English, French, 
Portuguese and Spanish, and from 2007 to 2017 were selected. That search resulted in 33 articles 
with the eligibility criteria. The journal “Periodontology 2000” has been also used as a 
complementary help for this review.  
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II. THEORETICAL FRAMEWORK 
 
1. Periodontal disease 
1.1 Definition and classification  
 
Periodontal diseases usually refer to common inflammatory disorders known as gingivitis and 
periodontitis which are caused by a pathogenic microbial infiltration of the periodontal tissues. 
This infiltration leads to a microscopically and clinically visible inflammation and immunological 
reactions (Nora Silva et al., 2015). 
Indeed, those bacteria induce the production of cytokines and chemokines by the gingival 
epithelium, resulting in the expression of adhesion molecules, increased permeability of gingival 
capillaries and attraction of polimorphonuclear neutrophils through the junctional epithelium and 
into the gingival sulcus. Then the inflammation spread deep into the tissues and causes loss of 
supporting connective tissue, and alveolar bone (Ford PJ et al., 2000). 
Various classifications of periodontal diseases were born during the years and replaced by new 
ones to improve our understanding of the etiology and pathology of periodontal diseases, and to 
provide better periodontal treatments. Also in order to facilitate professionals communication, and 
systematize information. The latest classification of periodontal diseases proposed by Gary 
Armitage in 1999 is presented in appendix 1. 
Gingivitis is an inflammatory lesion localized in the superficial periodontium, that means the 
gingival epithelium and the underlying connective tissue, without affecting the deep periodontal 
structures. Gingivitis is a reversible disease. Clinical signs of gingivitis include change of color, 
shape and texture of the gingiva (sign of inflammation), spontaneous or induced bleeding, localized 
pain and the appearance of false pockets of a gingival hypertrophy, without apical migration of the 
epithelial attachment (American Academy of Periodontology, 2017). 
Chronic periodontitis is an inflammatory and infectious diseases of all tissues supporting the teeth, 
leading to the progressive destruction of deep periodontal tissues. They are irreversible and are 
accompanied by migration of the junctional epithelium along the root of the tooth, leading to the 
appearance of periodontal pockets and gingival recessions, which are clinical signs of this affection 
(American Academy of Periodontology, 2017). 
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1.2 Etiology 
Periodontal health resides on the balance between all the elements of the periodontium and the 
ambient factors. If this equilibrium is not respected it can lead to periodontal disease. They are two 
types of risk factors, the modifiable ones and the non-modifiable ones, modifiable risk factors are 
usually environmental or behavioural in nature whereas the non-modifiable risk factors are intrinsic 
to the individual (Muhammad Ashraf Nazir, 2017).  
The responsible for the initiation of periodontal diseases are bacterial species living in the biofilms 
present on the gingiva or below the gingival margin, and they progress thanks to the inflammation 
initiated by specific subgingival species (Ricardo Teles et al.,2013). 
In the microflora of gingivitis, bacteria gram-positives coexist (Actinomyces naeslundii, 
Streptococcus sanguis, Fusobacterium nucleatum), present in healthy periodontal tissues, and 
bacteria gram-negatives (Tannerela forsythia, Treponema denticola, among others) which number 
increase with the progression of gingivitis (Lockart PB et al., 2012).   
The principal bacteria associated with the condition of periodontitis are T. forsythia, P. gingivalis, 
e T. denticola, called « the red complex », due to the vast factors of virulence that they present, 
leading to an inflammatory and immunological response of the host (Dentino et al., 2013). 
Despite the fact that bacteria are the principal etiological factor of gingivitis and periodontitis, this 
microbial aggression is not sufficient to induce periodontal disease. Indeed, the pathogenesis of 
periodontal diseases is complex and the susceptibility to it varies between individuals (Van Dyke 
TE, Sheilesh D, 2005).  
Kazor et al. (cit. in Genco e Borgnakke 2013) says that tobacco seems to increase the number of 
specific periodontal pathogenic agents such as P. gingivalis, T denticola and T. forsythia. Smoking 
also modify the host response to the challenge of bacteria in microbial dental plaque (Shchipkova 
AY et al., 2010). 
 
Diabetes is a modifiable factor because though it cannot be cured, it can be controlled. Studies have 
shown a relationship between poor glycemic control and periodontal disease parameters (Guzman 
et al., 2003; Tsai et al., 2002).  
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Stress has been linked, by many studies, with the development of clinical attachment loss and loss 
of alveolar bone (Hugoson et al., 2002; Pistorius et al., 2002; Wimmer et al., 2002). Maybe the 
relationship is due to the fact that individuals under stress are less likely to perform regular good 
oral hygiene and prophylaxis (Croucher et al., 1997). 
Regarding genetic risk factor, studies conducted on twins suggest that 50% of susceptibility to 
periodontal disease is due to host factors (Michalowicz et al., 2000). It appears that a genetic 
polymorphism is linked to a greater risk of developing periodontitis (Dentino et al., 2013). 
 
In osteoporosis, the low density present in the maxillary and mandibular bones causes an increase 
of porosity, alterations in the bone trabeculae pattern, and may lead to a greater reabsorption of the 
alveolar bone after the infection by the pathogens of the periodontium (Stabholz et al., 2010). 
 
Recent studies have suggested that obesity is associated with oral diseases, and particularly 
periodontitis (Dalla Vecchia CF et al., 2005). In fact, the adipose tissue secretes several cytokines 
and hormones that are involved in inflammatory processes, who could lead to tissue destruction of 
the periodontium (Dentino et al., 2013).  
 
Studies suggest that alcohol consumption is associated with moderately increased severity of 
periodontal disease. It’s a dose-dependency perspective, so the higher the alcohol consumption, the 
greater the severity of the loss of clinical insertion (Genco and Borgnakke, 2013). 
 
Finally, gender is also considered a risk factor. For years, it has been described that men of different 
ethnicities, geographical locations and of different ages have more periodontal disease than women 
(Genco and Borgnakke, 2013). 
 
 
1.3 Pathogenesis 
 
In 2008 Kornman reviewed the model of the pathogenesis of periodontal disease. He says that 
human periodontitis is initiated and perpetuated by a small group of predominantly gram-negative, 
anaerobic or microaerophilic bacteria that colonize the subgingival area, but that host factors are 
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essentials for the disease to occur and progress. 
Bacteria first triggers an innate inflammatory response, which is the first line of defense of the host, 
and is able to recognize those invading microorganisms as non-self. Microorganisms do this 
invasion through antigens, lipopolysaccharide (LPS) and other virulence factors, the host respond 
by releasing antibodies and leukocytes (PMNs), more precisely neutrophils. This innate response 
also results in the release of mast cells, macrophages, T and B lymphocytes and plasma cells (Page 
and Kornman, 1997; Sallum et al., 2004).  
This initial line of defense will activate the release of pro-inflammatory cytokines, namely IL-1, 
IL-6, IL-8 and TNFα who will signal fibroblasts to produce prostaglandins (PGE-2) and Matrix 
metalloproteases (MMPs). PGE-2 appears to be involved in bone destruction and MMPs in the 
destruction of connective tissue (Tülay YL and Tove B, 2013). 
 
So bacteria mostly cause the observed tissue destruction indirectly, and they do so by activating 
various components of the host defense systems in such a manner that destruction happens (Souza, 
J.A et al., 2012). 
 
2. Inflammation and regeneration in the periodontal disease 
2.1 Host defense mechanisms 
 
Periodontal inflammation is characterized by the appearance of vascular  and cellular changes 
leading to temporary or permanent deterioration of the constituents of normal tissues (cells, fibers, 
matrix). This results in alteration or loss of the normal function of the affected tissue. The main 
objective of this local inflammatory reaction is to protect the exposed tissue against the penetration 
of harmful substances and to establish favorable conditions for the regeneration or repair of 
damaged tissue structures (Hasturk H et al., 2015). 
 
Most of the microorganisms invading the periodontium have virulence factors capable of causing 
massive tissue destruction both directly, through tissue invasion and the production of virulent 
substances, or indirectly, by activation of host defense mechanisms, creating a powerful 
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inflammatory infiltrate that can interfere with normal host defense mechanisms. In response to this 
aggression, the host activates an innate immune response which is improved by an adaptive 
immune response leading to an efficient microbial clearance (Bascones-Martinez A et al., 2009). 
 
The first line of defense, the innate system, is triggered by Pattern Recognition Receptors (PRRs) 
that bind Pathogens-Associated Molecular Patterns (PAMPs). These receptors include toll-like 
receptors, nucleotide-binding oligomerization domain (NOD) proteins, cluster of differentiation 14 
(CD14), complement receptor-3, lectins and scavenger receptors (Takeda K, et al., 2001). 
The studies are mainly focused on toll-like receptors who recognize a large number of varied and 
complex pathogen-associated molecular patterns, and on neutrophils who are one of the first-
responders of inflammatory cells to migrate toward the site of periodontal inflammation. 
Polymorphonuclear neutrophils are the hallmark of acute inflammation. Although they are 
protective cells, their accumulation and massive death are the cause of tissue breakdown in 
progressive periodontitis (Van Dyke TE, 2007). 
Adaptive immunity cells and specific cytokines have been described as important players in the 
periodontal reaction to invaders, with a special attention to CD4+ T-cells (T-helper cells) (Cutler 
CW, Jotwani R, 2004). 
 
Despite all those protective systems, the persistent interaction between periodontal inflammation 
and bacterial infection up-regulates the expression and activity of neutral proteinases which 
contributes to the progressive breakdown of periodontal supporting tissue. Thus, the excessive host 
inflammatory response and/or inadequate resolution of inflammation seems to be critical to the 
pathogenesis of periodontal disease (Sorsa T, et al., 2011). 
 
2.2 Biological principles of periodontal regeneration 
Regeneration is the biological process by which the architecture and function of tissues injured 
during a pathological process are fully restored. It is the ad-integrum reconstruction of the 
attachment apparatus, cementum, ligament and alveolar bone around a tooth whose periodontium 
has been injured (American Academy of Periodontology, 2001). 
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An essential goal for intervention in inflammatory disease is the return of tissue to homeostasis. 
That is to say, the rapid and complete elimination of invading leukocytes from a lesion which is 
the ideal outcome following an inflammatory event (Van Dyke TE., 2007). 
 
At the end of the inflammatory process when there is a high concentration of proinflammatory 
products, such as prostaglandin E2 (PGE2), a “class switch” may occur within neutrophils. This 
leads to the synthesis of proresolving molecules through distinct pathways from those involved in 
the generation of proinflammatory lipid mediators. Those proresolving molecules include lipoxins 
that control the resolution phase of acute inflammation and promote healing of the lesion (Levy 
BD, et al., 2001).  
Others proresolving molecules such as resolvins and protectins have been discovered, and represent 
a potentially powerful intervention that stimulates resolution pathways leading to the restoration of 
homeostasis. They are capable of limiting polymorphonuclear neutrophil (PMN) migration into 
sites of inflammation, activating monocytes, and stimulating the uptake of apoptotic PMNs by 
macrophages (Serhan CN and Chiang N, 2008). 
However, with a defective immune response and the incapacity to return to homeostasis, 
periodontal inflammation can become chronic and can result in a prolonged inflammatory reaction 
and host tissue damage (Hasturk H et al., 2015). 
 
2.3 Factors that influence the healing process 
 
Periodontal healing is a complex biological process that consists of hemostasis, inflammation, 
proliferation, and remodelling. Single or multiple factors may play a role in one or more of those 
phases, contributing to the overall outcome of the healing process (Guo S and DiPietro LA, 2010). 
 
An increased age is a major risk factor for healing process. Indeed, it is recognized that the effect 
of aging causes a temporal delay in periodontal regeneration, mostly because of an altered 
inflammatory response (Swift et al., 2001).  
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Sex hormones play a role too in periodontal regeneration. Indeed, estrogen affects healing by 
regulating a variety of genes associated with regeneration, and the genes primarily associated with 
inflammation (Hardman and Ashcroft, 2008).  
 
The pathophysiology of stress results in the deregulation of the immune system. Thus, 
psychological stress impairs normal cell-mediated immunity, causing a significant delay in the 
healing process (Godbout and Glaser, 2006). 
 
Diabetic individuals exhibit a documented impairment in the healing of acute inflammation. 
Several dysregulated cellular functions are involved, these defects are responsible for inadequate 
bacterial clearance and delayed or impaired repair (Loots et al., 1998; Sibbald and Woo, 2008). 
Many medications, such as those which interfere with clot formation or platelet function, or 
inflammatory responses and cell proliferation have a significant impact on healing (Guo S and 
DiPietro LA, 2010). 
In obese persons, adipokines, coming from adipocytes, have a profound and negative impact on 
the immune and inflammatory response which seems to influence the healing process (Calabro and 
Yeh, 2007; Wozniak et al., 2009). 
Studies have demonstrated effects of alcohol on host-defense mechanisms, that results in 
suppressed pro-inflammatory cytokine release in response to an inflammatory challenge 
(Greiffenstein and Molina, 2008). 
 
Tobacco smoke seems to be affecting several cell types and processes that are important to healing 
(Ahn et al., 2008). 
 
Nutrition is also important in the process of healing. For example, vitamin C deficiencies leads to 
an impaired immune response and impaired healing (Campos et al., 2008).  
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3. Hyaluronic acid: its potential as a complement in the periodontal therapy 
3.1 Presentation of hyaluronic acid 
 
Hyaluronic acid (HA) was discovered and named in 1934 in the Department of Ophthalmology of 
the University of Colombia, by Mr Karl Meyer and Mr John Palmer. It is a polysaccharide isolated 
from the vitreous humor of the eye which contains a "non-sulfated" uronic acid bound to a 
hexosamine (Parveen D, Reet K, 2013). Since the international nomenclature of polysaccharides 
of 1984, it is also called "hyaluronan" (Nusgens BV, 2010). 
HA belongs to the family of glycosaminoglycans (GAG), indeed, it is constituted by repeating units 
of d-glucoronic acid and N-acetyl-d-glucosamine connected by a glycosidic bond β(1-3) (Laurent 
TC, Fraser JR, 1992).  
 
 
 
 
 
 
Fig.1: Chemical structure of HA (J. Mater and Chem. B, 2017) 
 
HA is found in all the organism, and especially in the extracellular matrix (ECM) of soft connective 
tissues (Laurent TC, Fraser JR, 1996). It has been identified in all periodontal tissues in varying 
quantities, being more prominent in the non-mineralized tissues compared to mineralized tissues 
(Vera RN et al., 2013). It is a key element in both tissue structure, cell signaling and tissue 
hemostasis. It regulates the cell-matrix and cell-cell exchanges as well as the entry and exit of 
nutrients and waste, all in physiological and pathological conditions (Vigetti D, et al., 2014). 
The production of intrinsic HA happens thanks to hyaluronan synthase (HAS) enzymes (HAS1, 
HAS2, and HAS3) in various cells from the periodontal tissues including fibroblasts, keratinocytes, 
cementoblasts, and osteoblasts (Ijuin C, Ohno S, et al., 2001). 
Prehm's study in 1984 showed that HA is synthesized on the internal face of the plasma membrane 
of the cell, and then directly secreted into the extracellular space. Then its turnover occurs by 
The potential of hyaluronic acid in the treatment of periodontal inflammation 
 10 
lymphatic drainage to the blood stream or by local metabolism involving specific enzymes named 
hyaluronidases. Those enzymes will permit to split the HA chains in small simple sugars that will 
be reusable in various metabolic cycles (Vigetti D, et al., 2014). 
Once AH has been synthesized, the molecules can be free in the extracellular space or remain 
attached to the plasma membrane by the HAS or via their specific receptor CD44, to form a layer 
of pericellular HA (Auvinen P et al., 2014). 
Released into the extracellular space, AH fragments are incorporated into the ECM and are capable 
of interacting via receptors with other components of the ECM to transmit different cellular signals 
and thereby influence the behavior of the cells, thus acting on their differentiation, migration, etc. 
(Itano N, 2008). Indeed, HA can have cell surface interactions and bind with transmembrane 
glycoproteins called "hyaladherins”. For example, the receptor CD44 discovered by Underhill et 
al. (Sherman L, et al., 1994) or RHAMM which mediates mobility discovered by Turley (Turley 
EA et al., 1991). 
When HA remains attached to the plasma membrane it forms a pericellular mantle ("glycocalyx") 
which permits for example the bonding of the ECM, or the regulation of cell proliferation and 
migration, but also the protection of cells against viruses or cytotoxic (Itano N, 2008). 
 
HA has two essential functions, a structural role because it is a constituent of the architecture of 
the tissues that increase the volume of the ECM by filling containing water and ions, and a 
regulating role of cell signalization because it interacts with constituents of the MEC and with 
membrane receptors (Vabres P, 2010). 
 
 
3.2 Applicability in periodontics 
 
 
Our knowledge of the mechanism of inflammation and healing process associated with periodontal 
disease showed us the potential of the components of the extracellular matrix as promoters of 
periodontal tissue regeneration and healing. Various studies supporting the role of those matrix 
components, highlighted hyaluronic acid as one possible candidate in regeneration of periodontal 
tissues (Vera RN et al., 2013). 
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Indeed, preliminary clinical trials conducted by Vangelisti and Pagnacco et al. in 1997 have shown 
that HA has anti-inflammatory, anti-edematous and anti-bacterial effects for the treatment of 
gingivitis and periodontitis. It plays an anti-inflammatory role through the inhibition of tissue 
destruction and facilitates healing, because it reduces prostaglandins, metalloproteinases and other 
bio-active molecules (Laurent TC et al., 1996). 
 
HA has numerous roles in the initial inflammatory stages, such as improved inflammatory cell 
infiltration into the inflammatory site, in order to speed up the gingival immune response. Indeed, 
Hakansson et al. said that HA has a role in migration and adherence of polymorphonuclear 
leukocytes and macrophages at the inflamed site, and phagocytosis and destruction of microbial 
pathogens. So HA directly prevents proliferation of anaerobic pathogenic bacteria. It also indirectly 
acts to moderate inflammation and stabilize the granulation tissue by preventing degradation of the 
ECM proteins by enzymes-protease of inflamed cells (Parveen D, Reet K, 2013). 
 
HA is also useful during granulation phase as it promotes cell proliferation, migration of matrix 
cells into granulation tissue matrix and granulation tissue organization (Bartold PM, Page RC, 
1986). In later stage of the granulation phase, HA synthesis ceases and existing HA is cut into 
molecules of lower molecular weight by hyaluronidases which leads to an alteration in the 
composition of the granulation tissue. Those small fragments of HA promote the formation of 
blood vessels (angiogenesis) within wound sites (Vera RN et al., 2013). 
 
Hyaluronic acid is a key component of chronic injuries during wound healing processes in 
periodontal tissues, mostly in the processes of inflammation, granulation tissue formation and 
restauration of the epithelium (Nora Silva et al., 2015). 
 
3.3 Applicability of HA as an adjuvant in the treatment of periodontal disease 
 
To treat oral diseases chemical usage is widely employed, and various antibiotics and anti-
inflammatory agents have been trailed in previous studies. However, recent initiatives have started 
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to use chemotherapeutic agents as a treatment of periodontal diseases, and HA is a recent addition 
to those (Sapna N, Vandana KL, 2011). 
In fact, HA is interesting using as an exogenous agent in the treatment of chronic inflammatory 
changes due to his role in the control of mechanisms of inflammation and tissue regeneration. 
Because it’s non-toxic, biocompatible, and it has numerous biochemical and physio-chemical 
features, its topical and systemic application offers a lot of benefit effects in the regulation of the 
host response (Vera RN et al., 2013). 
The treatment of gingivitis requires the teaching of oral hygiene techniques that permits plaque 
control, and the cleaning of  teeth surfaces to remove plaque and tartar. However after scaling, 
agents can be used locally by patients at home to maintain periodontal health (Caton J., 1989).  
Several studies have been conducted to study the efficacy of HA in the treatment of gingivitis. 
Sahayata in 2014 has showed that although scaling is effective in the treatment of gingivitis, its 
effect is enhanced by HA which reduces bleeding and flowing of the gingival fluid which acts as a 
microbial reservoir. In addition, he confirms that the topical use of HA as an anti-inflammatory 
agent improves significantly the clinical symptoms of the gingivitis.  
In his study of 2005 Pistorius evaluated the results of application of HA spray on patients with 
gingivitis, and those results have shown a significantly reduced papillary bleeding index (PBI) in 
the group having used this HA spray compared to the placebo group. 
 
The proprieties of HA also seem to be an asset for the treatment of periodontitis. 
Indeed, in 2002 Mesa has shown a beneficial effect of the use of HA alone, without any other 
associated periodontal treatment, on the inflammatory character of periodontitis. The results show 
a reduction of the inflammatory infiltrate, accompanied by a reduction in the gingival bleeding 
index (GBI). 
 
Scaling and Root Planning (SRP) is the first-line treatment for periodontitis with pockets and 
consists of stopping the inflammatory process by destabilizing and removing the pathogenic 
gingival biofilm and restoring an environment compatible with periodontal health (Heitz-Mayfield 
LJA, 2005). However, the effectiveness of SRP is dependent on the type of lesion and its access, 
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so topical application of subgingival HA gel can be used as an antimicrobial agent as an adjunct to 
SRP to overcome those limitations (Johannsen A et al., 2009). 
 
Bevilacqua in his study of 2012 suggested that subgingival application of HA following ultrasonic 
mechanical instrumentation is beneficial for improving periodontal parameters, and reducing 
bleeding and probing depth.  
Polepalle in 2015 showed a significant improvement in all clinical gingival parameters, GBI and 
gingival inflammation, and periodontal parameters, pocket depth and clinical attachment gain, 
following subgingival application of a gel 0.8% HA in addition to root debridement (SRP). As well 
as a bacteriostatic effect on certain pathogens. 
This beneficial effect of HA on gingival inflammation is also observed by Pilloni (2011) when used 
as an adjunct to mechanical home plaque control. And Gontiya (2012), who confirms the efficacy 
of SRP and concludes that HA improves clinical gingival parameters and helps prevent the 
progression of periodontal disease. 
Johannsen et al. (2009) evaluated the adjunctive effect of local application of 0.8% Hyaluronan gel 
to SRP in the treatment of chronic periodontitis and found out in addition to a statistically different 
decrease in the bleeding index, a pocket depth significantly decreased when hyaluronic acid is used. 
In addition, Eick (2012) concluded that HA stabilizes low rates of periodontal microbial flora, and 
prevents the re-growth of certain bacteria.  
 
 
III. DISCUSSION 
The question that served of fundament for the elaboration of this work was: “What are the potential 
effects of HA in the treatment of periodontal inflammation?”  
We have highlighted the fact that HA has anti-inflammatory, anti-edematous and bacteriostatic 
effects. Indeed, almost all studies show that HA has a strong interest in the treatment of periodontal 
disease and more precisely in periodontal inflammation. 
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Sahayata in 2014 pursued a study about the application of a 0,2% HA gel (Gengigel®) in the 
treatment of gingivitis after scaling compared to scaling alone. He found a statistical significant 
amelioration on the gingival index (GI) and the PBI in the HA group compared to the placebo 
group, but no microbiological improvement of inflammation. 
 
Two studies compared the efficacy of a HA gel applied after regular tooth brushing with regular 
tooth brushing alone (Pilloni et al., 2011, Mesa et al., 2002). They both concluded to a significant 
improvement of inflammation and bleeding, the following clinical indexes were improved: 
Bleeding on probing (BOP), Probing pocket depth (PPD), and GI. 
 
Four studies compared the outcomes of the application of a HA gel after SRP compared to the 
application of a placebo gel after SRP (Bevilacqua et al., 2012, Rajan et al., 2014, Gontiya et al., 
2012, Polepalle et al., 2015). The first two noticed a clinical improvement in the HA group with a  
significant amelioration in PPD and BOP, but Rajan (2014) noticed also an amelioration on the 
clinical attachment level (CAL). 
The results of the study of Gontiya (2012) showed an improvement of the gingival parameters in 
the HA group but not of the periodontal ones, indeed he noticed a significant amelioration in GI 
and GBI. He also analyzed the inflammatory infiltrate but did not found any significant differences 
between the two groups. 
On the contrary, Polepalle (2015) found a significant difference for the inflammatory infiltrate 
between the HA group and the placebo group. He noticed a significant improvement in BOP and 
PPD in the HA group, like Bevilacqua (2012) and Rajan (2014), but also in the plaque index (PI) 
for which he is the only one of all those studies. 
 
The results from the previous studies are opposed to Xu who, a few years earlier (2004), did not 
conclude an improvement of periodontal health following the use of HA in complement of a SRP 
(no clinical or microbiological improvement). But in this study the HA gel was only applied once 
a week for 6 weeks which is not enough compared to the recommended application level of 3 times 
per day for at least 4 to 8 weeks, and the levels of HA were well below optimum levels required to 
achieve a significant clinical improvement (Sahayata 2014).  
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Despite the fact that HA gel is a good adjuvant to periodontal disease treatment, it’s interesting to 
know if it has additional effects compared to other exogenous agents such as chlorhexidine (CHX).  
In his study in 2013, Chauhan compared the outcomes of a subgingival application of a HA gel 
after SRP, a CHX gel after SRP and SRP alone. After 3 months, there was a better amelioration of 
PPD and CAL in the HA group but it was non-significant compared to the CHX group, as well for 
the microbiological markers of inflammation. For some authors the CHX remains a reference agent 
in the treatment of periodontal disease but they suggest to use HA as an alternative to CHX in case 
of allergy or side effects. Further studies are needed in this field to better understand this topic 
(Chauhan AS, et al. 2013). 
 
 
 
IV. CONCLUSION 
 
HA is a natural component of our body and is abundant in the periodontal tissue, thus it can be 
used in humans without causing an immune or inflammatory response. 
It has viscoelastic properties which permits to act like a barrier against periodontal pathogens, and 
make it practical to use in the form of a gel, allowing an easy application.  
In addition, it has a proangiogenic, anti-inflammatory, and bacteriostatic role which influence 
positively the periodontal inflammation and healing when used alone or used as an adjuvant.  
Indeed, the majority of the studies exposed in this review of literature confirm that HA used as an 
adjuvant associated with scaling seems to obtain better results in the treatment of gingivitis than 
isolated scaling. 
In periodontitis, the combined treatment HA + SRP, presents more satisfactory results than the 
conventional treatment of SRP alone, in most of the outcome variables presented. 
All this suggests that hyaluronic acid is an adjuvant of choice in periodontal therapy. 
 
However, in order to simplify its use, studies still need to be carried out to specify the methods of 
administration and to establish proper recommendations. Thus, its use by general practitioners 
would be easier, more common and would improve the results of their periodontal treatments, 
leading to periodontal health and aesthetics in accordance with the patient's demand. 
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Appendix 1. Classification of periodontal disease, Workshop 1999 (Armitage GC 1999) 
 
 
 
 
 
 
 
 
 
 
 
Gingival disease 
Dental plaque-induced gingival diseases 
Gingivitis associated with dental plaque 
only 
Gingival disease modified by systemic 
factors 
Gingival disease modified by medications 
Gingival disease modified by malnutrition 
Non-plaque-induced gingival diseases 
Gingival disease of specific bacterial origin 
Gingival disease of viral origin 
Gingival disease fungal origin 
Gingival disease of genetic origin 
Gingival manifestations of systemic 
conditions 
Traumatic lesions 
Foreign body reactions 
Not otherwise specified 
Necrotizing periodontal disease 
Necrotizing ulcerative gingivitis 
Necrotizing ulcerative periodontitis 
Chronic periodontitis 
Localized 
Generalized 
Abscesses of the periodontium 
Gingival abscesses 
Periodontal  abscesses 
Pericoronal  abscesses 
Aggressive periodontitis 
Localized 
Generalized 
Periodontitis associated with endodontic lesions 
Combined periodontic-endodontic lesions 
Periodontitis as a manifestation of systemic 
diseases 
Associated with hematologic disorders 
Associated with genetic disorders 
Not otherwise specified 
Developmental of acquired deformities and 
conditions 
Localized tooth-related factors that modify or 
predispose to plaque-induced gingival 
diseases/periodontitis 
Mucogingival deformities and conditions around 
teeth 
Mucogingival deformities and conditions on 
edentulous ridges 
Occlusal trauma 
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APPENDIX 2 
 
The pathogenesis of human periodontitis (Roy C. Page & Kenneth S. Kornman, 
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Appendix 2. The pathogenesis of human periodontitis (Roy C. Page & Kenneth S. Kornman, 
1997) 
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APPENDIX 3 
 
Cytokines and periodontal disease (Journal of Applied Oral Science, 2015) 
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Appendix 3. Cytokines and periodontal disease (Journal of Applied Oral Science, 2015) 
 
 
 
 
